IRWD

Ironwood Pharmaceuticals, Inc.

5.99 USD
+0.01 (+0.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ironwood Pharmaceuticals, Inc. stock is down -8.69% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 73.33% of the previous 14 June’s closed higher than May.

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation.